Article Text

Download PDFPDF
PP-8 Transition instead of transfer for drug treatment in adolescent diabetes type 1
  1. Deters,
  2. Läer,
  3. Obarcanin
  1. Heinrich Heine University, DUESSSELDORF, Germany


Background Diabetes mellitus is one of the most com-mon diseases in childhood and the incidence increased over the past 20 years about 3%–4%. Micro-and macrovas-cular complications, due to poor metabolic control, can lead to long-term complications such as high blood pres-sure. Especially in adolescence lower medication adher-ence is a huge risk for complications. The DIADEMA study, a randomised controlled trial, has shown that community pharmacists can have a positive impact on therapy ad-justment and glycemic control of adolescent diabetes patients The objective of this analysis was to understand how the intervention provided by the community phar-macist can help to support transition of the adolescent into adulthood regarding drug treatment.

Method A quantitative, statistical analysis of the 39 inter-vention group patients case-report-forms was conduct-ed, to evaluate the impact of community pharmacists on the different outcomes e.g. fasting blood glucose levels. A Wilcoxon-signed-rank test or fisher-extact test were used to evaluate the difference in the amount of self-moni-toring of blood glucose (SMBG), daily insulin injections, average fasting blood glucose levels, insulintherapy ad-herence, daily insulin dose and number of patients, which are following their nutrition plan or doing exercise or hav-ing hypoglycemic episodes. Inconsistent and imprecise data were excluded from the statistical analysis. Missing data was marked with n.a. and before the analysis was conducted a significance level of alpha=0.05 was set.

Results The statistical analysis revealed that pharma-ceutical care provided by community pharmacists can support transition of the adolescent regarding drug treatment becasue it resulted in more frequent SMBG, a greater amount of patients complying to their individual nutrition plan and injecting the correct insulin dose. Ad-ditionally, the insulintherapy adherence increased and resulted in lower fasting blood glucose levels. However, all these changes did not lead to an increase of hypogly-cemic episodes.

Conclusion The DIADEMA study demonstrated that ad-olescent diabetes patients benefit from the community pharmacists´approach to guide transition of drug treat-ment into a self responsible behaviour. With this empow-erment patients achieved better glycemic control mea-sured by lower HbA1c-values (1). Better glycemic control can minimise the risk of short-and long-term diabetes related complications such as retinopathy or blindness.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.